Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.
Cristinziano G, Porru M, Lamberti D, Buglioni S, Rollo F, Amoreo CA, Manni I, Giannarelli D, Cristofoletti C, Russo G, Borad MJ, Grazi GL, Diodoro MG, Giordano S, Sacconi A, Forcato M, Anastasi S, Leonetti C, Segatto O. Cristinziano G, et al. Among authors: rollo f. J Hepatol. 2021 Aug;75(2):351-362. doi: 10.1016/j.jhep.2021.02.032. Epub 2021 Mar 17. J Hepatol. 2021. PMID: 33741397
A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
Terrenato I, D'Alicandro V, Casini B, Perracchio L, Rollo F, De Salvo L, Di Filippo S, Di Filippo F, Pescarmona E, Maugeri-Saccà M, Mottolese M, Buglioni S. Terrenato I, et al. Among authors: rollo f. PLoS One. 2017 Feb 10;12(2):e0171517. doi: 10.1371/journal.pone.0171517. eCollection 2017. PLoS One. 2017. PMID: 28187209 Free PMC article.
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.
Terrenato I, Ercolani C, Di Benedetto A, Gallo E, Melucci E, Casini B, Rollo F, Palange A, Visca P, Pescarmona E, Melis E, Gallina F, Sacconi A, Cecere FL, Landi L, Cappuzzo F, Ciliberto G, Buglioni S. Terrenato I, et al. Among authors: rollo f. Cancers (Basel). 2022 Jun 16;14(12):2971. doi: 10.3390/cancers14122971. Cancers (Basel). 2022. PMID: 35740637 Free PMC article.
HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S, Canu V, Donzelli S, Pulito C, Sacconi A, Ganci F, Valenti F, Goeman F, Scalera S, Rollo F, Bagnato A, Diodoro MG, Vizza E, Carosi M, Rufini B, Federici O, Giofrè M, Carboni F, Muti P, Ciliberto G, Strano S, Valle M, Blandino G. Di Agostino S, et al. Among authors: rollo f. Cell Death Dis. 2023 Aug 19;14(8):535. doi: 10.1038/s41419-023-06064-9. Cell Death Dis. 2023. PMID: 37598177 Free PMC article.
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Ganci F, Allegretti M, Frascolla C, Spinella F, Rollo F, Sacconi A, Valentina P, Palcau AC, Manciocco V, Vescovo M, Cotroneo E, Blandino F, Benevolo M, Covello R, Muti P, Strano S, Vidiri A, Fontemaggi G, Pellini R, Blandino G. Ganci F, et al. Among authors: rollo f. Biomark Res. 2024 Mar 5;12(1):32. doi: 10.1186/s40364-024-00576-y. Biomark Res. 2024. PMID: 38444004 Free PMC article.
Correction: Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer.
Ganci F, Allegretti M, Frascolla C, Spinella F, Rollo F, Sacconi A, De Pascale V, Palcau AC, Manciocco V, Vescovo M, Cotroneo E, Blandino F, Benevolo M, Covello R, Muti P, Strano S, Vidiri A, Fontemaggi G, Pellini R, Blandino G. Ganci F, et al. Among authors: rollo f. Biomark Res. 2024 Mar 26;12(1):37. doi: 10.1186/s40364-024-00582-0. Biomark Res. 2024. PMID: 38532476 Free PMC article. No abstract available.
167 results